Evidence map›Paper›PMID 36776432›Full record

ArticleLancet regional health. Americas2022

Finding and treating early-stage HIV infections: A cost-effectiveness analysis of the

Angela K Ulrich, Blythe J Adamson, Enrique M Saldarriaga, Robert De La Grecca, Daniel Wood, Joseph B Babigumira, Jorge L Sanchez, Javier R Lama, Dobromir Dimitrov, Ann Duerr

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Angela K UlrichCenter for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis, MN, USA.
Blythe J AdamsonInfectious Economics, New York, NY, USA.
Enrique M SaldarriagaThe Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.
Robert De La GreccaHIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Daniel WoodVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Joseph B BabigumiraSaw Swee Hock School of Public Health, National University of Singapore, Singapore.
Jorge L SanchezCentro de Investigaciones Tecnologicas Biomedicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Perú.
Javier R LamaAsociación Civil Impacta Salud y Educación, Lima, Perú.
Dobromir DimitrovVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ann DuerrVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Funding

SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
NIAID NIH HHS UM1 AI068617
6 · The paper itself

Abstract

Background: Methods: We adapted a compartmental model of HIV transmission to evaluate the cost-effectiveness of the Findings: The Interpretation: Our analysis suggests that in Lima, Peru the Funding: National Institutes of Health.

Indexed as

Acute infectionARTCost-effectivenessEarly primary infectionHIV preventionMathematical model

Identifiers

PMID36776432
PMCPMC9903945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.